Jordi Ponce: “Endometrial cancer molecular diagnostic test represents a revolution in diagnostic precision.”

The head of the Gynecology Service of Bellvitge University Hospital and Vice-President of Oncology Section of SEGO participated in the session “Molecular biology applied to the screening of endometrial cancer“, in the framework of the 11th edition of the course “Caring for Health Of Women: Initiatives and Challenges“. This specialist has highlighted the innovative role of the GynEC®-DX kit in the clinical practice for diagnosing endometrial cancer.


See interview (in Spanish)